Drabkin H A
West J Med. 1985 Dec;143(6):825-8.
In the past few years, new developments have rapidly emerged that promise to unravel the pathogenesis of malignant transformation. By understanding the molecular events in neoplastic transformation, such as in myelogenous leukemia, we should be able to devise specific and effective therapies and to intervene in the development of these diseases. Furthermore, the study of cancer genes is likely to have far-reaching effects with regard to our understanding of normal development and other nonneoplastic conditions.
在过去几年中,迅速出现了一些新进展,有望揭示恶性转化的发病机制。通过了解肿瘤转化过程中的分子事件,比如骨髓性白血病中的分子事件,我们应该能够设计出具体有效的治疗方法,并干预这些疾病的发展。此外,癌症基因的研究对于我们理解正常发育和其他非肿瘤性疾病可能会产生深远影响。